中国医学创新
中國醫學創新
중국의학창신
Medical Innovation of China
2015年
26期
1-3
,共3页
苏立军%刘玉法%高丽%陈广新%刘学伍
囌立軍%劉玉法%高麗%陳廣新%劉學伍
소립군%류옥법%고려%진엄신%류학오
神经节苷脂%依达拉奉%迟发性脑病%有效率%MMSE%MBI
神經節苷脂%依達拉奉%遲髮性腦病%有效率%MMSE%MBI
신경절감지%의체랍봉%지발성뇌병%유효솔%MMSE%MBI
Ganglioside%Edaravone%Delayed encephalopathy%Efficiency%MMSE%MBI
目的:探讨神经节苷脂联合依达拉奉治疗一氧化碳中毒迟发型脑病的临床疗效。方法:将本科收治的87例一氧化碳中毒迟发性脑病患者随机分为对照组(n=42)及试验组(n=45),两组均接受高压氧、抗血小板聚集、改善微循环、促进脑代谢等常规治疗;试验组在此基础上加用神经节苷脂及依达拉奉治疗,观察两组患者的治疗效果,采用简易智力状态量表(MMSE)和改良Barthel指数(MBI)量表评价两组患者治疗前、后的认知功能和日常生活活动能力。结果:对照组治疗总有效率为76.2%,试验组为93.3%,差异有统计学意义(P<0.05)。与治疗前相比,两组治疗后的MMSE评分、MBI评分均明显提高(P<0.05);与治疗后的对照组相比,试验组治疗后MMSE评分、MBI评分也有明显提高(P<0.05)。结论:神经节苷脂联合依达拉奉治疗一氧化碳中毒迟发型脑病,可明显改善患者的预后,并明显改善患者的认知能力和日常生活能力。
目的:探討神經節苷脂聯閤依達拉奉治療一氧化碳中毒遲髮型腦病的臨床療效。方法:將本科收治的87例一氧化碳中毒遲髮性腦病患者隨機分為對照組(n=42)及試驗組(n=45),兩組均接受高壓氧、抗血小闆聚集、改善微循環、促進腦代謝等常規治療;試驗組在此基礎上加用神經節苷脂及依達拉奉治療,觀察兩組患者的治療效果,採用簡易智力狀態量錶(MMSE)和改良Barthel指數(MBI)量錶評價兩組患者治療前、後的認知功能和日常生活活動能力。結果:對照組治療總有效率為76.2%,試驗組為93.3%,差異有統計學意義(P<0.05)。與治療前相比,兩組治療後的MMSE評分、MBI評分均明顯提高(P<0.05);與治療後的對照組相比,試驗組治療後MMSE評分、MBI評分也有明顯提高(P<0.05)。結論:神經節苷脂聯閤依達拉奉治療一氧化碳中毒遲髮型腦病,可明顯改善患者的預後,併明顯改善患者的認知能力和日常生活能力。
목적:탐토신경절감지연합의체랍봉치료일양화탄중독지발형뇌병적림상료효。방법:장본과수치적87례일양화탄중독지발성뇌병환자수궤분위대조조(n=42)급시험조(n=45),량조균접수고압양、항혈소판취집、개선미순배、촉진뇌대사등상규치료;시험조재차기출상가용신경절감지급의체랍봉치료,관찰량조환자적치료효과,채용간역지력상태량표(MMSE)화개량Barthel지수(MBI)량표평개량조환자치료전、후적인지공능화일상생활활동능력。결과:대조조치료총유효솔위76.2%,시험조위93.3%,차이유통계학의의(P<0.05)。여치료전상비,량조치료후적MMSE평분、MBI평분균명현제고(P<0.05);여치료후적대조조상비,시험조치료후MMSE평분、MBI평분야유명현제고(P<0.05)。결론:신경절감지연합의체랍봉치료일양화탄중독지발형뇌병,가명현개선환자적예후,병명현개선환자적인지능력화일상생활능력。
Objective:To study the efficiency of Ganglioside plus Edaravone in the treatment of delayed encephalopathy after acute carbon monoxide poisoning.Method:87 cases of delayed encephalopathy caused by carbon monoxide poisoning admitted to our department, were randomly divided into two groups:the control group( n=42) was given conventional hyperbaric oxygen,preventing platelet aggregation,improving microcirculation,improving cerebral metabolism and other conventional treatment;the experimental group( n=45) was given Ganglioside( 100 mg, intravenous drip 1/d), Edaravone( 30 mg, intravenous drip 2 /d) for 21 days on the basis of the control group. The efficiency of two groups were observed and their cognitive function and daily life activity with the mini-mental state examination( MMSE) and modified Barthel index( MBI) before treatment and after treatment were evaluated.Result:The efficiency of the control group was 76.2%, the efficiency of the experimental group was 93.3%(P<0.05). MMSE score and MBI score of the control group and experimental group after treatment were higher than those of before treatment(P<0.05);MMSE score and MBI score of the experimental group were obviously higher than those of the control group after treatment (P<0.05).Conclusion:Application of Ganglioside plus Edaravone in the treatment of delayed encephalopathy after acute carbon monoxide poisoning can obviously improve the prognosis of delayed encephalopathy, and significantly improve the patients’ cognitive ability and daily life ability.